Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Setler

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|August 1, 1984
Pyrroloisoquinoline antidepressants. Potent, enantioselective inhibition of tetrabenazine-induced ptosis and neuronal uptake of norepinephrine, dopamine, and serotoninB E Maryanoff, D F McComsey, M J Castanzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Preclinical evaluation of McN-5707 as a potential antidepressantR P Shank, J F Gardocki, C R Schneider, et al.
Journal of Medicinal Chemistry|June 1, 1982
Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineC Kaiser, P A Dandridge, E Garvey, et al.
Journal of Medicinal Chemistry|August 1, 1987
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationshipsB E Maryanoff, D F McComsey, J F Gardocki, et al.
Journal of Medicinal Chemistry|April 1, 1982
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesF R Pfeiffer, J W Wilson, J Weinstock, et al.
Journal of Medicinal Chemistry|September 1, 1980
6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neurolepticsC Kaiser, F E Ali, W E Bondinell, et al.
Journal of Medicinal Chemistry|September 1, 1980
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepinesJ Weinstock, J W Wilson, D L Ladd, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|August 1, 1984
Pyrroloisoquinoline antidepressants. Potent, enantioselective inhibition of tetrabenazine-induced ptosis and neuronal uptake of norepinephrine, dopamine, and serotoninB E Maryanoff, D F McComsey, M J Castanzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Preclinical evaluation of McN-5707 as a potential antidepressantR P Shank, J F Gardocki, C R Schneider, et al.
Journal of Medicinal Chemistry|June 1, 1982
Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineC Kaiser, P A Dandridge, E Garvey, et al.
Journal of Medicinal Chemistry|August 1, 1987
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationshipsB E Maryanoff, D F McComsey, J F Gardocki, et al.
Journal of Medicinal Chemistry|April 1, 1982
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesF R Pfeiffer, J W Wilson, J Weinstock, et al.
Journal of Medicinal Chemistry|September 1, 1980
6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neurolepticsC Kaiser, F E Ali, W E Bondinell, et al.
Journal of Medicinal Chemistry|September 1, 1980
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepinesJ Weinstock, J W Wilson, D L Ladd, et al.
Pageof 3